Oral ganciclovir approved. [news] Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Oral ganciclovir approved. [news] Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Treat Issues. 1995 Jan;9(1):10. Unique Identifier : AIDSLINE AIDS/95700119
Gold D

Abstract: The Food and Drug Administration has approved oral ganciclovir (Cytovene) as a maintenance therapy for cytomegalovirus (CMV) infections of the retina. As an alternative to the intravenous form of the drug, oral ganciclovir would free patients with CMV from the need for daily 2-hour infusions after the first two or three weeks of treatment. The drawback of oral ganciclovir is that it is somewhat less effective than the infused form, which delays CMV progression for several months.
Keywords: Administration, Oral Cytomegalovirus Infections/COMPLICATIONS/*DRUG THERAPY Ganciclovir/*ADMINISTRATION & DOSAGE/THERAPEUTIC USE Human Infusions, Intravenous Retinitis/COMPLICATIONS/*DRUG THERAPY NEWSLETTER ARTICLE NEWSKWDadministration,oralcytomegalovirusinfections/complications/KWDdrugtherapyganciclovir/KWDadministration&dosage/therapeuticusehumaninfusions,intravenousretinitis/complications/KWDdrugtherapynewsletterarticlenews
950530
M9551020

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .